| 1 |
Duthaler U, Leisegang R, Karlsson MO, Krähenbühl S, Hammann F. The effect of food on the pharmacokinetics of oral ivermectin. J Antimicrob Chemother 2020;75:438-40. [PMID: 31691813 DOI: 10.1093/jac/dkz466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 2 |
Boullata JI. Drug-Nutrition Interactions in Infectious Diseases. Nutrition and Infectious Diseases 2021. [DOI: 10.1007/978-3-030-56913-6_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Boullata JI. Drug-nutrition interactions. Reference Module in Food Science 2021. [DOI: 10.1016/b978-0-12-821848-8.00012-3] [Reference Citation Analysis]
|
| 4 |
Chaccour C, Abizanda G, Irigoyen-Barrio Á, Casellas A, Aldaz A, Martínez-Galán F, Hammann F, Gil AG. Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats. Sci Rep 2020;10:17073. [PMID: 33051517 DOI: 10.1038/s41598-020-74084-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 5 |
Al Jalali V, Zeitlinger M. Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents. Clin Pharmacokinet 2020;59:827-47. [PMID: 32100246 DOI: 10.1007/s40262-020-00871-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 6 |
Makenga Bof JC, Muteba D, Mansiangi P, Ilunga-Ilunga F, Coppieters Y. Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo. BMC Pharmacol Toxicol 2019;20:49. [PMID: 31420005 DOI: 10.1186/s40360-019-0327-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 7 |
Verrest L, Dorlo TPC. Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic Review. Clin Pharmacokinet 2017;56:583-606. [PMID: 27744580 DOI: 10.1007/s40262-016-0467-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 8 |
Schulz JD, Neodo A, Coulibaly JT, Keiser J. Development and validation of a LC-MS/MS method for ivermectin quantification in dried blood spots: application to a pharmacokinetic study in Trichuris trichiura -infected adults. Anal Methods 2018;10:2901-9. [DOI: 10.1039/c8ay00828k] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 9 |
Chaccour C, Hammann F, Rabinovich NR. Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety. Malar J 2017;16:161. [PMID: 28434401 DOI: 10.1186/s12936-017-1801-4] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 10.5] [Reference Citation Analysis]
|
